Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10660971 Compounds for targeted immunotherapy

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 5 Jun, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 5 Jun, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11998620 PSMA targeted compounds and uses thereof
0
Edits on 7 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11834448 2-amino-quinoline derivatives
0
Edits on 18 Oct, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 18 Oct, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11786604 Compounds and compositions for treating HER2 positive tumors
Edits on 26 Jul, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 26 Jul, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11708393 Targeted non-invasive imaging probes of EGFR expressing cells
0
Edits on 21 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 21 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=106609710
Edits on 30 Apr, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 30 Apr, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11633495 Compounds and compositions for immunotherapy
0
"update inverses"
Golden AI profile picture
Golden AI
edited on 30 Apr, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11633494 Compounds and compositions for immunotherapy
0
Edits on 26 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 26 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
106609710
Date of Patent
May 26, 2020
0
Patent Application Number
158494700
Date Filed
December 20, 2017
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=106609710
Patent Citations
‌
US Patent 10328158 Compounds and compositions for immunotherapy
0
Patent Citations Received
‌
US Patent 11400164 Immunoconjugates targeting HER2
0
‌
US Patent 11517567 Pharmaceutical compositions
0
‌
US Patent 11547761 Antibody adjuvant conjugates
0
Patent Primary Examiner
‌
Shulamith H. Shafer
0
Edits on 5 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 5 Apr, 2023
Infobox
Patent Citations Received
‌
US Patent 11517567 Pharmaceutical compositions
0
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 4 Apr, 2023
Edits on 11 Jan, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 11 Jan, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11547761 Antibody adjuvant conjugates
0
Edits on 7 Dec, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Dec, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11517567 Pharmaceutical compositions
0
Edits on 3 Aug, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 3 Aug, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 11400164 Immunoconjugates targeting HER2
Edits on 8 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 8 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=10660971
Edits on 3 Feb, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 3 Feb, 2022
Edits made to:
Infobox (+8 properties)
‌

 US Patent 10660971 Compounds for targeted immunotherapy

Infobox
Is a
Patent
Patent
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
10660971
Date of patent
May 26, 2020
Patent application number
15849470
Date Filed
December 20, 2017
Patent citations
‌
US Patent 10328158 Compounds and compositions for immunotherapy
Patent primary examiner
‌
Shulamith H. Shafer

Find more entities like US Patent 10660971 Compounds for targeted immunotherapy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo